Skip to main
PEPG

PepGen Inc (PEPG) Stock Forecast & Price Target

PepGen Inc (PEPG) Analyst Ratings

Based on 6 analyst ratings
Strong Buy
Strong Buy 67%
Buy 33%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

PepGen is a clinical-stage biotechnology company with a promising platform for delivering oligonucleotide therapeutics to target tissues, including muscle and the central nervous system. Despite some early data concerns, the company has a strong pipeline with PGN-EDODM1 as the lead candidate. The upcoming FREEDOM-2 data in 2H26 will be a key catalyst for the stock, and while we remain positive on the potential of PGN-EDODM1, we have lowered our target to $5 due to increased safety concerns.

Bears say

PepGen is a clinical-stage biotechnology company that has developed a platform to improve the uptake and activity of oligonucleotide therapeutics. However, their PGN-EDODM1 drug has faced challenges, including a clinical hold and concerning splicing data in early trials. Additionally, the company may face delays or challenges in obtaining external funding. These factors, along with a recent increase in discount rate and a lowered valuation, contribute to the negative outlook on PepGen's stock.

PepGen Inc (PEPG) has been analyzed by 6 analysts, with a consensus rating of Strong Buy. 67% of analysts recommend a Strong Buy, 33% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of PepGen Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About PepGen Inc (PEPG) Forecast

Analysts have given PepGen Inc (PEPG) a Strong Buy based on their latest research and market trends.

According to 6 analysts, PepGen Inc (PEPG) has a Strong Buy consensus rating as of Aug 28, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $11.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $11.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

PepGen Inc (PEPG)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.